An in vivo model for elucidation of the mechanism of tumor necrosis factor-α (TNF-α)-induced insulin resistance: Evidence for differential regulation of insulin signaling by TNF-α

Endocrinology

Volumn 139, Issue 12, 1998, Pages 4928-4935

  Cheung, Anthony T ^a   Ree, Daniel ^c   Kolls, Jay K ^b   Fuselier, Joseph ^a   Coy, David H ^a   Bryer Ash, Michael ^c,d  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; INSULIN; INSULIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TYROSINE; VIRUS VECTOR;

ADENOVIRUS 5; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC OBESITY; GENE TRANSFER; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR AFFINITY;

EID: 0031756640     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.12.6336     Document Type: Article

References (34)

1. DeFronzo RA, Ferrannini E 1996 Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194
2. Hollenbeck CB, Chen YD-I, Reaven GM 1984 A comparison of the relative effects of obesity, and NIDDM on in vivo insulin-stimulated glucose utilization. Diabetes 33:622-626
3. Hotamisligil GS, Shargill NS, Spiegelman BM 1993 Adipose expression of TNF-α: direct role in obesity-linked insulin resistance. Science 259:87-91
4. Hotamisligil GS, Budavari A, Murray DL, Spiegelman BM 1994 Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes: central role of TNF-α. J Clin Invest 94:1543-1549
5. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS 1997 Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389:610-914
6. Graham FL, Provec L In: Murray EJ (ed) Methods in Molecular Biology. Humana, Clifton, NJ, pp 109-128
7. Peppel K, Crawford D, Beutler B 1991 A TNF receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity. J Exp Med 174:1483-1489
8. Bryer-Ash M 1991 Regulation of rat insulin receptor kinase by glucose. in vivo. Diabetes 40:633-640
9. Steele R 1959 Influence of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82:420-443
10. Harder KW, Owen P, Wong LK, Aebersold R, dark-Lewis I, Jirik FR 1994 Characterization, and kinetic analysis of the intracellular domain of human protein tyrosine phosphatase β (HPIPβ) using synthetic phosphopeptides. Biochem J 298:395-401
11. Ullrich A, Bell JR, Chen EY, Herrera R, Petruzelli LM, Dull TJ, Gray A, Coussens L, Liao YC, Tsubokawa M 1985 Human insulin receptor, and its relationship to the tyrosine kinase family of oncogenes. Nature 313:756-761
12. dark-Lewis I, Moser B, Walz A, Baggiolini M, Scott GJ, Aebersold R 1991 Chemical synthesis, purification, and characterization of two inflammatory proteins, neutrophil activating peptide 1 (interleukin 8) and neutrophil activating peptide. Biochemistry 30:3128-3135
13. Brand C, Sorensen A, Gronemann S, Hansen B, Press K, Carr R 1997 Evidence that TNFα immunoneutralization does not improve insulin sensitivity in obese Zucker rats. Diabetes 47(Suppl 1):228A
14. Kolls J, Peppel K, Silva M, Beutler B 1994 Prolonged, and effective blockade of TNF activity through adenovirus-mediated gene transfer. Proc Natl Acad Sci USA 91:215-219
15. White MF, Kahn CR 1994 The insulin signaling system. J Biol Chem 269:1-4
16. Lang CH, Dobrescu C, Bagby GJ 1992 Tumor necrosis factor impairs insulin action on peripheral glucose disposal, and hepatic glucose output. Endocrinology 130:43-52
17. Worm D, Handberg A, Hoppe E, Vinten J, Beck-Nielsen H 1996 Decreased skeletal muscle phosphotyrosine phosphatase activity towards insulin receptors in insulin resistant Zucker rats measured by europium fluorescence. Diabetologia 39:142-148
18. Cheung A, Bryer-Ash M, Jansen D, Bandyopadhyay D, Kusari A, and Kusari J 1997 Protein tyrosine phosphatase 1B (PTP-1B) activity is markedly impaired despite increased PTP-1B levels in adipose tissue of obese humans. Diabetes 46(Suppl 1):282A
19. Ahmad F, Azevedo Jr JL, Cortright R, Dohm GL, Goldstein BJ 1997 Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. J Clin Invest 100:449-458
20. Worm D, Vinten J, Staehr P, Henriksen JE, Handberg A, Beck Nielsen H 1996 Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects. Diabetologia 39:1208-1214
21. Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS, Spiegelman BM 1994 Altered gene expression for tumor necrosis factor-α, and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134:264-270
22. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA 1996 The expression of TNF-α by human muscle: relationship to insulin resistance. J Clin Invest 97:1111-1116
23. Kern PA, Saghizadeh M, Ong JM, Bosch R, Deem R, Simsolo RB 1995 The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss and relationship to lipoprotein lipase. J Clin Invest 95:2111-2119
24. Yamauchi K, Milarski KL, Saltiel AR, Pessin JE 1995 Protein-tyrosine-phosphatase SHPTP 2 is a required positive effector for insulin downstream signaling. Proc Natl Acad Sci USA 92:664-668
25. Ren J-M, Li P-M, Zhang W-R, Sweet LJ, Cline G, Shulman GI, Livingston JN, Goldstein BJ 1998 Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis. Diabetes 47:493-487
26. Svedberg J, Bjomtorp P, Smith U, Lonnroth P 1992 Effect of free fatty acids on insulin receptor binding, and tyrosine kinase activity in hepatocytes isolated from lean and obese rats. Diabetes 41:294-298
27. Hennes MM, Shrago E, Kissebah AH 1990 Receptor and postreceptor effects of free fatty acids (FFA) on hepatocyte insulin dynamics. Int J Obes 14:831-841
28. Mittelman SD, Fu YY, Rebrin K, Steil G, Bergman RN 1997 Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia. J Clin Invest 100:3121-3130
29. Unger R 1995 Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic, and clinical implications. Diabetes 44:863-870
30. Hotamisligil GS, Spiegelman BM 1994 Tumor necrosis factor-alpha: a key component of the obesity-diabetes link. Diabetes 43:1271-1278
31. Stratford-Perricaudet LD, Makeh I, Perricaudet M, Briand P 1992 Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest 90:626-630
32. Fisher KJ, Jooss K, Alston J, Yang Y, Haecker SE, High K, Pathak R, Raper SE, Wilson JM 1997 Recombinant adeno-associated virus for muscle directed gene therapy. Nature Med 3:306-312
33. Ventre J, Doebber T, Wu M, MacNaul K, Stevens K, Pasparakis M, Kollias G, Moller DE 1997 Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice. Diabetes 46:1526-31
34. Sun XJ, Wang LM, Zhang Y, Yenush L, Myers MG, Glasheen EM, Lane WS, Pierce JH, White MF 1995 Role of IRS- 2 in insulin and cytokine signaling. Nature 377:173-177